Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 12th Annual Conference on Nephrology & Urology Seri Pacific Hotel, Kuala Lumpur, Malaysia.

Day 1 :

Keynote Forum

Ralf Oettmeier

Stellar Biomolecular Research (SBR) and FCTI Germany

Keynote: Basics and examples of successful treatment of uro-nephrological diseases in the context of CAM

Time : 9:30-10:05

OMICS International Nephrology & Urology 2017 International Conference Keynote Speaker Ralf Oettmeier photo
Biography:

Dr. R. Oettmeier had his medical studying at the Friedrich-Schiller-University Jena Germany.From 1993 – 2014 he worked in his own outpatient department with the focus on reflex therapies (Chirotherapy, Acupuncture, Neural Therapy), Homeopathy and special pain treatment and as leading head physician in the Clinic im LEBEN at Greiz, Germany. Since 2014 he is leading Doctor at the Paracelsus Clinic Lustmühle, Switzerland, a Comprehensive Center for Biologic-Integrative Medicine and Dentistry. He realizes considerable activities of seminars and presentations in the fields of Biological Medicine, is author of textbooks and publications in CAM, and finally of some guidebooks for patients. 

Abstract:

Additional to conventional basics, complementary and alternative medicine (CAM) also uses evidence-based aspects from environmental medicine (toxins, physical irritating fields), the vegetative nervous system (reflex zones, sympathetic-parasympathetic balance, somatotopies, odontomas), energetic medicine (acupuncture meridians of TCM, chakras from Ayurvedic medicine) as well as approved psycho-mentally and psycho-emotionally relationships. The uro-nephrological system is clearly embedded in this holistic context, which enables a clear diagnostic strategy to develop an individual therapeutic concept. With the usage of this thinking it is possible to treat the deep reasons of the diseases even more. Mostly, it is necessary to reduce the environmental toxic load, to optimize the dental situation and to diminish chronic neuro-modulative triggers (foci) with the help of neural therapy. Next, we pay attention to the intestinal health and immune system. Finally, the patient’s own healing forces were activated by using a big palette of natural remedies and organ cell therapy. The examples of chronic cystitis, nephrotic syndrome and prostate cancer illustrate the successful application of CAM in this fields.

Keynote Forum

Michael D Wagener

Stellar Biomolecular Research (SBR) and FCTI Germany

Keynote: The role of intravenous phospholipds as a membrane therapeutic - a complementary treatment approach of CKD

Time : 10:05-10:40

OMICS International Nephrology & Urology 2017 International Conference Keynote Speaker Michael D Wagener photo
Biography:

Michael D Wagener has received a Medical Degree from the University of Berlin, Germany, in 1991. During his Post-graduate training, he was trained in General Internal Medicine, Pneumology and Allergology in Davos (Switzerland). He received board certification in General Internal Medicine, Allergology and Pharmaceutical Medicine and Neuraltherapy. In 1997, he joined Eli Lilly as a Clinical Research Physician, in 2005 Novartis Pharma in Basel and in 2009 he became Chief Medical Officer of AC Immune in Lausanne (Switzerland). Since 2000, he was a member of the Executive Board of the Swiss Association of Pharmaceutical Medicine (SGPM) and in 2002 to 2008 he was elected President of this Organization. Since 2010, he is the Owner of an “Antiaging and Complementary Medicine Center” in Basel.

Abstract:

Phosphatidylcholine is a phospholipid that is one of the main components of lecithin. Lecithin is found in all cell membranes and plays a major role in maintaining the fluidity of the cell by affecting what enters and leaves the cell through the cell membrane. Given as infusion, PC might improve many conditions, among them kidney function and overall energy. Clinical studies have been performed in glomerulonephritis, where a reduction of edema could be observed. Also in renal insufficiency patients showed an increase in creatinine, urine volume and renal clearance when receiving PC intravenously. Overall patients suffering from fatigue from various causes (e.g. chronic kidney disease) were benefiting from phosphatidylcholine infusions. Standard toxicological assessments indicate no significant acute or chronic toxicity from PC, as well as no mutagenicity and no teratogenicity.